No black box warning on record for Ojemda

As of the latest FDA labeling reviewed, Ojemda (TOVORAFENIB) does not carry a black box warning. Standard warnings and precautions still apply — see the full Ojemda medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Hemorrhage: Major hemorrhagic events can occur during treatment with OJEMDA. Withhold, resume at reduced dose, or permanently discontinue based on severity. ( 5.1 ) Skin Toxicity Including Photosensitivity : Advise patients to monitor for new or worsening skin reactions. Advise patients to limit direct ultraviolet exposure and use precautionary measures such as sunscreen

No black box warning on record for Ojemda

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Hemorrhage: Major hemorrhagic events can occur during treatment with OJEMDA. Withhold, resume at reduced dose, or permanently discontinue based on severity. ( 5.1 ) Skin Toxicity Including Photosensitivity : Advise patients to monitor for new or worsening skin reactions. Advise patients to limit direct ultraviolet exposure and use precautionary measures such as sunscreen

Ojemda Black Box Warning

No black box warning on record for Ojemda

Other warnings & precautions

Ojemda Black Box Warning

No black box warning on record for Ojemda

Other warnings & precautions